LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,113
تعداد مقالات10,208
تعداد مشاهده مقاله40,780,184
تعداد دریافت فایل اصل مقاله8,803,957
Babaloo, Zohreh, Babaie, Farhad, Farhoodi, Mehdi, Aliparasti, Mohammadreza, Baradaran, Behzad, Almasi, Shohreh, Hosseini, Ahmad. (1389). Interleukin-17A and Interleukin-17F mRNA Expressions in Peripheral Blood Mononuclear Cells of Patients with Multiple Sclerosis. سامانه مدیریت نشریات علمی, 7(4), 1-1.
Zohreh Babaloo; Farhad Babaie; Mehdi Farhoodi; Mohammadreza Aliparasti; Behzad Baradaran; Shohreh Almasi; Ahmad Hosseini. "Interleukin-17A and Interleukin-17F mRNA Expressions in Peripheral Blood Mononuclear Cells of Patients with Multiple Sclerosis". سامانه مدیریت نشریات علمی, 7, 4, 1389, 1-1.
Babaloo, Zohreh, Babaie, Farhad, Farhoodi, Mehdi, Aliparasti, Mohammadreza, Baradaran, Behzad, Almasi, Shohreh, Hosseini, Ahmad. (1389). 'Interleukin-17A and Interleukin-17F mRNA Expressions in Peripheral Blood Mononuclear Cells of Patients with Multiple Sclerosis', سامانه مدیریت نشریات علمی, 7(4), pp. 1-1.
Babaloo, Zohreh, Babaie, Farhad, Farhoodi, Mehdi, Aliparasti, Mohammadreza, Baradaran, Behzad, Almasi, Shohreh, Hosseini, Ahmad. Interleukin-17A and Interleukin-17F mRNA Expressions in Peripheral Blood Mononuclear Cells of Patients with Multiple Sclerosis. سامانه مدیریت نشریات علمی, 1389; 7(4): 1-1.

Interleukin-17A and Interleukin-17F mRNA Expressions in Peripheral Blood Mononuclear Cells of Patients with Multiple Sclerosis

Iranian Journal of Immunology
مقاله 1، دوره 7، شماره 4، اسفند 2010، صفحه 1-1    اصل مقاله (13.21 K)
نوع مقاله: Original Article
نویسندگان
Zohreh Babaloo* 1، 2؛ Farhad Babaie1؛ Mehdi Farhoodi2؛ Mohammadreza Aliparasti1؛ Behzad Baradaran1؛ Shohreh Almasi1؛ Ahmad Hosseini1، 3
1Immunology Department, Medicine Faculty
2Neuroscience Research Center, Tabriz University of Medical Sciences,Tabriz, Iran
3Institute for Cancer Research, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Bakground: Multiple sclerosis (MS) is a CD4+ T cell-mediated autoimmune disease affecting the central nervous system (CNS). It was previously believed that Th1 cells were pathogenic T cells in experimental autoimmune encephalomyelitis (EAE). However, the functional role of Th1 cells in EAE has been reconsidered upon the discovery of IL-17- producing T cells which are consider as dominant effectors for inducing autoimmune tissue inflammation.
Objective: The objective of this study was to assess the role of IL-17A and IL-17F in MS pathogenesis.
Methods: We evaluated mRNA expression of IL-17A and IL-17F in thirty-five Iranian patients with relapsing–remitting MS (RRMS) and twenty-five healthy controls by Quantitative Real Time PCR.
Results: The results of this study showed a twenty-fold increase in the expression of IL-17A mRNA in MS patients compared to the control group (p < 0.0001 ). IL-17F mRNA expression in MS patients was thirty three-times greater than control group (p = 0.0008). IL-17A mRNA expression in periphery was positively correlated with expression of IL-17F transcripts in MS patients and controls (p < 0.01 and p < 0.05, respectively).
Conclusion: These results indicate the critical role of Th17- mediated cytokines in development of MS which classically has been considered as a Th1-mediated disorder. The results of this study showed, for the first time, the importance of IL-17F in MS immunopathogenesis.
کلیدواژه‌ها
Multiple Sclerosis (MS)؛ IL-17A؛ IL-17F؛ mRNA gene expression
آمار
تعداد مشاهده مقاله: 1,240
تعداد دریافت فایل اصل مقاله: 681


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب